Creating therapeutic abundance - by Jacob Kimmel - Creode

The invention of new medicines is rate limited by our knowledge of cells and molecules ("targets") that we can manipulate to treat disease. The cost of discovering new medicines has increased because the lowest hanging fruit has been picked on the tree of ideas. Emerging technologies at the intersection of artificial intelligence & genomics have the potential to unlock a new era of target abundance, potentially reversing the decade's long decline in R&D productivity. If realized, this will be one of the most important impacts of AI over the coming decades. Thanks for reading Creode! Subscribe for free to receive new posts. Gordon Moore famously predicted in 1965 that the number of transistors per integrated circuit would double every two years. The computing industry delivered. Jack Scannell infamously predicted in 2012 that the number of drugs per billion dollars would decline two-fold every nine years. Unfortunately, our therapeutics industry has largely followed through1. Eroom's la

The invention of new medicines is rate limited by our knowledge of cells and molecules ("targets") that we can manipulate to treat disease. The cost of discovering new medicines has increased because the lowest hanging fruit has been picked on the tree of ideas. Emerging technologies at the intersection of artificial intelligence & genomics have the potential to unlock a new era of target abundance, potentially reversing the decade's long decline in R&D productivity. If realized, this will be one of the most important impacts of AI over the coming decades. Thanks for reading Creode! Subscribe